Evidence map›Paper›PMID 9809728›Full record

Trial reportJAMA1998

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

R A Patchell, P A Tibbs, W F Regine, R J Dempsey, M Mohiuddin, R J Kryscio, W R Markesbery, K A Foon, B Young

8 registry-linked trialsAbstract readClinical TrialMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in JAMA, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 8 registered trials, which are not on this map. Cited by 659 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
659citing papers in PubMed, 15 pooled it
18.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00582075 phase2completednot on this mapstarted 2002, after this paper: background citation

Phase II Study of Gamma Knife Radiosurgery and Temozolomide (Temodar) for Newly Diagnosed Brain Metastases

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2002 to 2015Enrolled25ConditionsCancer, Brain MetastasesArmstemozolomide
NCT01395407 phase1completednot on this mapstarted 2011, after this paper: background citation

Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Intra-axial Brain Metastases

TypeinterventionalSponsorEmory UniversityRan2011 to 2015Enrolled9ConditionsBrain Metastasis, NeoplasmArmsRadiosurgery dose escalation
NCT01703507 phase1completednot on this mapstarted 2012, after this paper: background citation

Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases

TypeinterventionalSponsorSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityRan2012 to 2018Enrolled17ConditionsRecurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to BrainArmsIpilimumab, Whole-Brain Radiation Therapy (WBRT), Stereotactic Radiosurgery (SRS)
NCT01861405 unknown statusnot on this mapstarted 2013, after this paper: background citation

Neurocognitive and fMRI Activation Changes Observed at Baseline and After Whole Brain Radiation vs. Radiosurgery for Patients With Cerebral Metastases: a Prospective Case-control Analysis.

TypeobservationalSponsorThomas Jefferson UniversityRan2013Enrolled60ConditionsCerebral Metastases PatientsArmsneuropsychological testing and quality of life assessments, Standard of Care WBRT or SRS, Functional magnetic resonance imaging
NCT01890278 naunknown statusnot on this mapstarted 2013, after this paper: background citation

Randomized Phase II Trial of Conventional vs IMRT Whole Brain Radiotherapy for Brain Metastases

TypeinterventionalSponsorGood Samaritan Hospital Medical Center, New YorkRan2013 to 2017Enrolled60ConditionsMetastatic Brain CancerArmsWhole Brain IMRT, Conventional Whole Brain RT
NCT02390518 phase1recruitingnot on this mapstarted 2015, after this paper: background citation

Phase I Study of Stereotactic Radiosurgery Dose Escalation for Brain Metastases

TypeinterventionalSponsorUniversity of UtahRan2015 to 2029Enrolled86ConditionsBrain MetastasesArmsStereotactic Radiosurgery
NCT03414944 naunknown statusnot on this mapstarted 2016, after this paper: background citation

Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain Metastases,A Phase I,One-arm Trial

TypeinterventionalSponsorShandong Cancer Hospital and InstituteRan2016 to 2018Enrolled30ConditionsBrain MetastasesArmsSMART-Brain
NCT03726359 narecruitingnot on this mapstarted 2017, after this paper: background citation

Phase I TITE-CREM Dose Escalation Study of Fractionated Stereotactic Radiation Therapy (FSRT) in Unresected Brain Metastases

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2017 to 2027Enrolled43ConditionsBrain MetastasesArmsFractionated Stereotactic Radiation Therapy (FSRT)
3 · Its place in the literature

Who cites it

659 citing papers in PubMed, 15 syntheses or guidelines pooled it, 1,903 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Efficacy and safety evaluation of combined therapies incorporating whole-brain radiotherapy in patients with brain metastases: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Pooled it
  7. Pooled it
  8. DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024
    Guideline
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Guideline
  15. Pooled it
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

599 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

R A PatchellDepartment of Neurosurgery, University of Kentucky Medical Center, Lexington 40536-0084, USA. RPatchell@aol.com
P A Tibbs
W F Regine
R J Dempsey
M Mohiuddin
R J Kryscio
W R Markesbery
K A Foon
B Young
University of Kentucky · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextFor the treatment of a single metastasis to the brain, surgical resection combined with postoperative radiotherapy is more effective than treatment with radiotherapy alone. However, the efficacy of postoperative radiotherapy after complete surgical resection has not been established.

objectiveTo determine if postoperative radiotherapy resulted in improved neurologic control of disease and increased survival.

designMulticenter, randomized, parallel group trial.

settingUniversity-affiliated cancer treatment facilities. PATIENTS: Ninety-five patients who had single metastases to the brain that were treated with complete surgical resections (as verified by postoperative magnetic resonance imaging) between September 1989 and November 1997 were entered into the study.

interventionsPatients were randomly assigned to treatment with postoperative whole-brain radiotherapy (radiotherapy group, 49 patients) or no further treatment (observation group, 46 patients) for the brain metastasis, with median follow-up of 48 weeks and 43 weeks, respectively.

main outcome measuresThe primary end point was recurrence of tumor in the brain; secondary end points were length of survival, cause of death, and preservation of ability to function independently.

resultsRecurrence of tumor anywhere in the brain was less frequent in the radiotherapy group than in the observation group (9 [18%] of 49 vs 32 [70%] of 46; P<.001). Postoperative radiotherapy prevented brain recurrence at the site of the original metastasis (5 [10%] of 49 vs 21 [46%] of 46; P<.001) and at other sites in the brain (7 [14%] of 49 vs 17 [37%] of 46; P<.01). Patients in the radiotherapy group were less likely to die of neurologic causes than patients in the observation group (6 [14%] of 43 who died vs 17 [44%] of 39; P=.003). There was no significant difference between the 2 groups in overall length of survival or the length of time that patients remained functionally independent.

conclusionsPatients with cancer and single metastases to the brain who receive treatment with surgical resection and postoperative radiotherapy have fewer recurrences of cancer in the brain and are less likely to die of neurologic causes than similar patients treated with surgical resection alone.

Indexed as

AdultAgedBrain NeoplasmsFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeoplasm Recurrence, LocalNeuropsychological TestsRadiotherapy, AdjuvantSurvival Analysis

Identifiers

PMID9809728
OpenAlexW2003917401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.